SpyBiotech
PrivateLast Round
Grant
Mar 20, 2023
Est. Valuation
$9.73M
Total Funding Raised
$58.68M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SpyBiotech operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Grant round in March 2023.
SpyBiotech is a biotechnology company that develops vaccines against infectious diseases and cancer using its proprietary protein superglue technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpyBiotech Comparables
Compare SpyBiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nCage Therapeutics | 79% | |
| Mevox | 76% | |
| AstraZeneca | 71% |
For institutional investors. Book with your work email.
SpyBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 20, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Series A | Feb 10, 2021 | ||||
| Convertible Debt | Sep 1, 2020 | ||||
| Seed | Mar 31, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpyBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Series A |
| GV | Seed, Series A |
| Oxford Science Enterprises | Convertible Debt, Series A, Seed |
| British Business Bank | Series A |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Oxford Investment Consultants | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 493% MoM, reaching 1.8K.
- Jul 29, 2025
Stuart Chaffee joins as an independent member of the Board of Directors.
For institutional investors. Book with your work email.
SpyBiotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpyBiotech's valuation, stock price, and market status.
Is SpyBiotech a public or private company?
SpyBiotech is a private company.
What is the current stock price of SpyBiotech?
SpyBiotech is a private company, so its shares have no public market price. Caplight tracks SpyBiotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpyBiotech worth (valuation)?
SpyBiotech's valuation is estimated at $9.7M based on funding round data.
Can I buy SpyBiotech stock?
SpyBiotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpyBiotech's last funding round?
SpyBiotech's most recent funding round was Grant on March 20, 2023.
Who are the main investors in SpyBiotech?
Key investors in SpyBiotech include Braavos Investment Advisers, Oxford Science Enterprises.
Will SpyBiotech IPO soon?
No public IPO plans have been announced for SpyBiotech.
How can I track SpyBiotech secondary market activity?
Caplight tracks bids, offers, and trades in SpyBiotech's shares on secondary markets.